Patients as Partners, March 3-4, 2014, Philadelphia

Date: Dec-02-2013Patients as Partners (March 3-4, 2014, Philadelphia) takes a comprehensive view of the patient experience and how we engage with patients across the entire clinical trial continuum. This includes early research, patient-centric protocol design, recruitment, retention, engagement, and communicating results with patients acting as ambassadors and educators.

The Conference Forum is proud to present Patients as Partners with CISCRP's founder Ken Getz as conference chair, along with an exciting speaking faculty representing industry, advocacy, academia, patients and the FDA. Together, they address the latest strategies, technologies and policies to vastly improve the patient experience in clinical trials. The conference addresses how sponsors of clinical trials can realistically partner with patients and how patients can partner with sponsors to meet the demands of:

Evolving Science: Personalized Medicine
Higher Quality Data
Lower Dropout Rates
New Therapies Faster to Market

Patients as Partners takes a broad view of the patient experience and how we engage with patients across the entire clinical trial continuum. This includes early research, patient-centric protocol design, recruitment, retention, engagement, and communicating results with patients acting as ambassadors and educators.

"If you put the patient lens in front, you start to come up with some really solid answers and solutions." - Jeffrey Kasher, PhD, Eli Lilly

The conference is designed for clinical trial executives in pharma and biotech, directors in patient advocacy and academia, and service providers who are looking to incorporate the patient perspective throughout the clinical trial process, valuing patients and treating them as partners, ultimately leading to more successful clinical trials. Take advantage of the first early bird and register by December 20th.

Speaking Faculty:
Annette Bar-Cohen, MA, MPH, Executive Director, Center for NBCC Advocacy Training, National Breast Cancer Coalition

Lily Cappelletti, Associate Director, Research Partnerships, The Michael J. Fox
Foundation for Parkinson's Research

Lama Chahine, MD, Instructor of Neurology, Parkinson's Disease and Movement
Disorders Center,University of Pennsylvania

Jacqueline Cole, Clinical Operations Portfolio Management, Oncology, Eli Lilly

Maria Corvez, Clinical Research Manager II, Millennium Pharmaceuticals

Iris Culbert, Senior Clinical Project Manager, Global Clinical Operations, Teva
Pharmaceuticals

Daniel Davis, Oncology Business Unit Advisor, Eli Lilly

Victoria DiBiaso, Head of Investigator & Patient Networks, Sanofi Genzyme

Adam Dole, Presidential Innovation Fellow, The White House*

Ken Getz, MBA, Director of Sponsored Research / Founder, Tufts CSDD / CISCRP

Stuart Horowitz, PhD, MBA, President, Global Professional Services, WIRB Copernicus
Group

Andreas Koester, MD, PhD, VP, Clinical Trial Innovation & External Alliances, Janssen

Craig Lipset, MBA, Head of Clinical Innovation, R&D, Pfizer

Debra Lounsbury, Principal Scientist, BioMarin

Kimberly McCleary, Director, Strategic Initiatives, FasterCures

Nariman Nasser,Digital Strategist, Genentech

Bray Patrick-Lake, BS, MFS, Director of Stakeholder Engagement, Clinical Trials
Transformation Initiative

Christine Pierre, President, Society for Clinical Research Sites

Tomasz Sablinski, MD, PhD, Founder & CEO, Transparency Life Sciences

Jean Slutsky, PA, MSPH, Director, Center for Outcomes and Evidence Agency for
Healthcare Research and Quality

Komathi Stem, Senior Director, Product Development, Innovation Lead, Genentech

Andrea Tan, Operations Research Analyst, Office of Strategic Programs, CDER, FDA

Ronnie Todaro, Vice President, National Programs / Co-Chair, Parkinson's Disease Foundation / CTTI Patient Leadership Council

Jennifer Wulff, Director, Clinical Innovation, Pfizer*

Anthony Yanni, Head of Patient Value & Strategy, Sanofi Genzyme

*Invited speakers

For further information please click here.

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.